The frequency of the TP53 R337H variant was observed in 2.36% of the sporadic breast cancer cases we evaluated, with an increase of 7.71 in genotypic frequency (2.36% versus 0.306%) when considering all 214,087 newborns tested by Custódio et al.5 and Costa et al.4. Here, TP53 is linked to breast carcinoma.